Resolute Advisors’s MetLife MET Stock Holding History

Resolute Advisors’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-220	Closed	-$14K	–	393
2021 Q3	$14K	Hold	220	–	–	﹤0.01%	276
2021 Q2	$13K	Hold	220	–	–	﹤0.01%	245
2021 Q1	$13K	Buy	+220	New	+$12.1K	﹤0.01%	209

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Resolute Advisors's MET Position: Q4 2021 in Review

Resolute Advisors sold out of MetLife (MET) in Q4 2021, closing a stake of 220 shares — an estimated $14K sold.

Resolute Advisors first reported a position in MET in Q1 2021 and held it in 3 quarters. The position peaked at $14K in Q3 2021. 1,193 funds tracked by Wall St. Rank hold MET as of Q4 2021.

Resolute Advisors reported no remaining MetLife position as of Q4 2021 after selling out during the quarter.
Resolute Advisors sold 220 MetLife shares in Q4 2021, an estimated $14K.
Resolute Advisors first reported a position in MetLife in Q1 2021 and held it in 3 quarters.
Resolute Advisors's MetLife position peaked at $14K in Q3 2021.
1,193 funds tracked by Wall St. Rank held MetLife as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.